Skip to content

Perkins Coie LLP. logo
HomeAbout UsOur TeamContact
logonotch

1600 PTAB & Beyond

Significant Patent Decisions and Developments Affecting The Life Sciences Industry

Subscribe

Subscribe By Email

 

Subscribe by RSS/XML

Click the orange icon above, or copy and paste the following URL into your feedreader:

http://feeds.feedburner.com/1600PtabBeyond

About This Blog

Perkins Coie’s 1600 PTAB and Beyond blog reports from the intersection of the life sciences industry and key decisions and developments from the Patent Trial and Appeal Board (PTAB), district courts and appellate courts. We focus on IP analyses and insights within a practical and actionable context.

Stay Connected

RSS LinkedIn Facebook Twitter youtube

Topics

  • Amendments
  • ANDAs
  • Anticipation
  • Appeals
  • Claim Construction
  • District Court Proceedings
  • Estoppel
  • Evidentiary Issues
  • Experts
  • Federal Circuit
  • Final Written Decisions
  • Informative
  • Institution Decisions
  • IPR
  • Joinder
  • Obviousness
  • Parallel Proceedings
  • Patent Eligibility
  • PGR
  • POP
  • Precedential
  • Prior Art
  • PTAB Procedures
  • PTAB Tech Center 1600 Round-Up Archive
  • Section 101
  • Section 102
  • Section 112
  • Supreme Court
  • USPTO
  • Venue

Archives

Recent Posts

  • Method Claims Relying On A Naturally-Occurring Phenomenon Are Patent-Eligible Where They Recite “Human-Engineered Parameters”
  • New PTAB Informative Decisions: Applying the Fintiv Factors in View of Parallel District Court Litigation
  • Federal Circuit confirms that the PTAB can consider the patent eligibility of substitute claims proposed during an IPR
  • PTAB Issues Precedential Decision to Clarify 35 U.S.C. § 317(b) Collateral Agreements, and Three Informative Decisions
  • USPTO announces proposed rule changes on presumptions at institution and briefing permitted for patent owners during trial, among others

Perkins Coie Blogs

  • Asset Management ADVocate
  • California Land Use & Development Law Report
  • Cannabis Legal Highlights
  • Consumer Finance Legal Report
  • Consumer Protection Review
  • Derivatives & Repo Report
  • Food Litigation News
  • Founder Tip of the Week
  • N.D.Pa.L.
  • Privacy Quick Tips
  • The Fintech Report
  • Trade Secret Tracker
  • Virtual Currency Report
  • White Collar Briefly

1600 PTAB & Beyond

Significant Patent Decisions and Developments Affecting The Life Sciences Industry

RSS LinkedIn Facebook Twitter youtube

Perkins Coie LLP

AUSTIN |
ANCHORAGE |
BEIJING |
BELLEVUE |
BOISE |
CHICAGO |
DALLAS |
DENVER |
LOS ANGELES
MADISON |
NEW YORK |
PALO ALTO |
PHOENIX
PORTLAND |
SAN DIEGO |
SAN FRANCISCO |
SEATTLE |
SHANGHAI |
TAIPEI |
WASHINGTON, D.C.

About This Blog

Perkins Coie’s 1600 PTAB and Beyond blog reports from the intersection of the life sciences industry and key decisions and developments from the Patent Trial and Appeal Board (PTAB), district courts and appellate courts. We focus on IP analyses and insights within a practical and actionable context.

Copyright © 2020, Perkins Coie LLP. All Rights Reserved.
  • Privacy Policy
  • Disclaimer
Powered By LexBlog